AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

653.313

-17.154-2.56%

Number of Gainers:5

Number of Losers:19

Number of Flat:19

PE:- -

High:668.086

Open:663.064

Low:648.088

Close:670.467

Volume:40.56M

Turnover:346.36M

Market Cap:91.73B

Float Cap:88.35B

Loading ...

Founder Led Stocks With Long Term Skin In The Game

Simply Wall St.

Avita Medical Says Clinical Study for Biosynthetic Wound Matrix Meets Primary Endpoint

MT Newswires Live

Invion Ltd-Ivx Credentialed International Biotech Leader Joins Board

THOMSON REUTERS

ASX Stocks Estimated To Be Trading Below Fair Value In August 2026

Simply Wall St.

Haemonetics Shares Rise After Signing Supply Agreement With CSL Plasma

MT Newswires Live

Asia Morning Call-Global Markets

Haemonetics Signs Non-Exclusive US Plasma Supply Deal with CSL Plasma for NexSys PCS Devices, Disposables

CSL (ASX:CSL) Shares Confront Profit Reversal As Recovery Case Stays Unproven

Simply Wall St.

Switzerland's Basilea H1 Revenue Rises on Cresemba Demand; Ups 2026 Profit Outlook

CSL's Fiscal 2026 Results In Line, Jefferies Says

MT Newswires Live

Csl FY Adjusted Net Income USD 3,100 Million

Shares of CSL Limited up 12.9% at A$152 in Early Trade After Annual Results

THOMSON REUTERS

CSL FY26 Underlying NPATA Falls 2% to Us$3.1 Billion; Reported Net Loss Widens to Us$2.6 Billion

CSL Final Dividend Us$1.62 Per Share

THOMSON REUTERS

CSL Limited - Announce a Further A$1.1 Billion Share Buy-Back Program

THOMSON REUTERS

CSL Limited - Recognised Pre-Tax Impairments of $5.5 Billion in 2H FY26

THOMSON REUTERS

CSL Limited Sees FY Underlying Npat Growth of Approximately 5%

THOMSON REUTERS

CSL Limited - Intention to Spend Approximately $1.5 Billion to Expand Its U.S. Plasma Manufacturing Presence

THOMSON REUTERS

CSL FY Adjusted Net Income USD 3,100 Million

THOMSON REUTERS

CSL Limited - CSL Seqirus Expects Low Single Digit Revenue Growth in FY

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK7508/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":653.31305,"timestamp":1787291999902,"preClose":670.46686,"halted":0,"volume":40562994,"delay":0,"changeRate":-0.025585,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-17.153809,"latestTime":"08-21 16:00:00 AEST","open":663.06445,"high":668.0863,"low":648.08826,"amount":346356360,"amplitude":0.029827,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787270400000,1787292000000]],"turnoverRate":0.001591,"increases":7,"decrements":19,"flats":17,"marketCap":91731621721,"floatMarketCap":88350073177.75},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":668.0863,"amplitude":0.029827,"preClose":670.46686,"low":648.08826,"latestPrice":653.31305,"volume":40562994,"delay":0,"open":663.06445,"prevYearClose":644.3692,"prevWeekClose":541.582,"prevMonthClose":488.077,"prevQuarterClose":464.145,"fiveDayClose":541.582,"twentyDayClose":459.552,"sixtyDayClose":415.403,"secType":"PLATE","market":"AU","turnoverRate":0.001591,"marketCap":91731621721,"floatMarketCap":88350073177.75,"timestamp":1787291999902,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":5,"down":19,"flat":19},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660580416","title":"Founder Led Stocks With Long Term Skin In The Game","url":"https://stock-news.laohu8.com/highlight/detail?id=2660580416","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660580416?lang=en_us&edition=fundamental","pubTime":"2026-08-19 08:28","pubTimestamp":1787099319,"startTime":"0","endTime":"0","summary":"Global government bond yields are climbing as inflation worries and higher oil prices keep borrowing costs under pressure. That backdrop makes dependable leadership even more valuable because access to capital can quickly separate strong companies from the rest. Founder led businesses often have leaders with deep personal commitment and long time horizons. This article highlights three stocks from the Founder Led Companies screener that show how that mindset can matter.\nThe stocks in the...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-with-long-term-skin-in-the-game-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-with-long-term-skin-in-the-game-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7070","MAQ.AU","BK7067","BK7046","BK7042","FLT.AU","BK7508","MSB.AU","BK7511","MQG.AU","BK7501","BK7043"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660186464","title":"Avita Medical Says Clinical Study for Biosynthetic Wound Matrix Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2660186464","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660186464?lang=en_us&edition=fundamental","pubTime":"2026-08-19 07:54","pubTimestamp":1787097259,"startTime":"0","endTime":"0","summary":"Avita Medical  said its multicenter, randomized controlled clinical study for PermeaDerm, a biosynthetic wound matrix, met its primary endpoint, showing statistically significant superiority for mean cost per percent total body surface area treated, according to a Wednesday Australian bourse filing.The study enrolled 40 patients across 11 US burn centers, with wounds of up to 30% total body surface area. After excision, patients were randomized to receive either PermeaDerm or cadaveric allograft during the temporization period before definitive split-thickness skin grafting.Mean treatment cost was AU$148.70 for every 1% total body surface area treated with PermeaDerm, compared with AU$497.10 for allograft, representing a savings of around AU$348 per percent total body surface area.Around 94% of patients treated with PermeaDerm achieved at least 95% graft take one week following autografting, comparable to allograft, and all patients in both groups achieved 95% or greater wound healing ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","AVH.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660490054","title":"Invion Ltd-Ivx Credentialed International Biotech Leader Joins Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490054?lang=en_us&edition=fundamental","pubTime":"2026-08-19 07:22","pubTimestamp":1787095324,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nTUE3N4Y4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IVX.AU","BK7509","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660497250","title":"ASX Stocks Estimated To Be Trading Below Fair Value In August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660497250","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660497250?lang=en_us&edition=fundamental","pubTime":"2026-08-19 03:04","pubTimestamp":1787079872,"startTime":"0","endTime":"0","summary":"As the Australian market grapples with the implications of rising oil prices and their potential inflation impacts, investors are increasingly looking for opportunities within sectors that may be trading below their intrinsic value. In such a climate, identifying undervalued stocks can be particularly advantageous, as these investments often offer significant potential for growth when broader market conditions stabilize.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pnv/polynovo-shares/news/asx-stocks-estimated-to-be-trading-below-fair-value-in-augus","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pnv/polynovo-shares/news/asx-stocks-estimated-to-be-trading-below-fair-value-in-augus","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FDV.AU","DECU","SPHQ","BK7508","BK7062","BK4585","NWH.AU","SYL.AU","SLC.AU","BK7501","BK7002","BK7126","COH.AU","BK7055","VOTE","BK7067","NGI.AU","BK4588","PMDE","BK7104","PNV.AU","BK7007","BK7015","NXL.AU","GMD.AU","BK7016","XRO.AU","MSB.AU","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660149195","title":"Haemonetics Shares Rise After Signing Supply Agreement With CSL Plasma","url":"https://stock-news.laohu8.com/highlight/detail?id=2660149195","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660149195?lang=en_us&edition=fundamental","pubTime":"2026-08-19 02:40","pubTimestamp":1787078411,"startTime":"0","endTime":"0","summary":"Haemonetics  shares were up more than 17% in afternoon trading on Tuesday after the company said it entered into a supply agreement with CSL Plasma last week.The deal involves Haemonetics' NexSys PCS plasma collection system with Persona Plus Technology, an automated cell separator system, along with related disposables in the US, according to a Tuesday filing.CSL is expected to transition a portion of its US plasma collection centers to Haemonetics' devices and disposables, but the scope and timing of the implementation are still to be determined, the company said.Price: 105.99, Change: +15.72, Percent Change: +17.41","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","IE00B64QTZ34.USD","BK4086","CSL.AU","LU0728928796.USD","LU0106261612.USD","LU0012050646.USD","LU1169590202.USD","LU0205194284.USD","SG9999004303.SGD","SGXZ23171101.USD","IE00BLDYK493.USD","BK7508","BK7067","BK4198","IE0034390439.USD","CSL","HAE","IE00B19Z6F94.USD","LU1169589451.USD","BK7511","LU0205193047.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660916144","title":"Asia Morning Call-Global Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2660916144","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660916144?lang=en_us&edition=fundamental","pubTime":"2026-08-19 02:39","pubTimestamp":1787078393,"startTime":"0","endTime":"0","summary":"Asia Morning Call-Global MarketsAug 19 (Reuters)-Stock MarketsNet ChngStock MarketsNet ChngS&P/ASX 200**9070.00-3.20NZX 50**13866.18144.20DJIA53377.48-82.30NIKKEI**67460.73-1,759.52Nasdaq26316.48-327.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL4N44F14G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU1267930730.SGD","LU2210149790.SGD","LU2210150020.SGD","CSL.AU","LU0289739343.SGD","LU0390134368.USD","FDIQ","LU0511384066.AUD","LU1804176565.USD","LU2265009873.SGD","LU0289961442.SGD","MSCI","LU1691799644.USD","LU0109391861.USD","BK7511","BK4585","BK4588","BK7501","LU0320765059.SGD","LU0672654240.SGD","LU2095319765.USD","LU0175139822.USD","LU0708995401.HKD","BK7067","LU0289960550.SGD","BK7508","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660466734","title":"Haemonetics Signs Non-Exclusive US Plasma Supply Deal with CSL Plasma for NexSys PCS Devices, Disposables","url":"https://stock-news.laohu8.com/highlight/detail?id=2660466734","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660466734?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:06","pubTimestamp":1787047565,"startTime":"0","endTime":"0","summary":"Haemonetics signs non-exclusive US plasma supply deal with CSL Plasma for NexSys PCS devices, disposablesHaemonetics signed a non-exclusive U.S. supply agreement with CSL Plasma on Aug. 14, 2026 for N","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLpVv5B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","IE00B19Z6F94.USD","IE00B64QTZ34.USD","HAE","LU0205194284.USD","IE00BLDYK493.USD","LU1169590202.USD","IE0034390439.USD","BK7067","LU0106261612.USD","BK7511","CSL.AU","LU1169589451.USD","BK4198","LU0012050646.USD","BK7508","LU0205193047.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660466219","title":"CSL (ASX:CSL) Shares Confront Profit Reversal As Recovery Case Stays Unproven","url":"https://stock-news.laohu8.com/highlight/detail?id=2660466219","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660466219?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:22","pubTimestamp":1787044958,"startTime":"0","endTime":"0","summary":"CSL stock went into this result having climbed over the past quarter, closing at A$157.82, yet the latest numbers land with a jolt. The global biotech giant posted a trailing twelve month loss from continuing operations of US$2.99b on revenue of US$15.80b. That kind of earnings squeeze grabs short term traders by the throat. For long term investors, the real question now is how to weigh that loss against analyst forecasts that point to a return to profitability, as well as the current gap...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-shares-confront-profit-reversal-as-recovery-case","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-shares-confront-profit-reversal-as-recovery-case","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PMDE","LU0728928796.USD","DECU","BK7067","FEBU","JOYT","GXDW","BK4086","CSL.AU","CSL","SG9999004303.SGD","RGLO","LU1169589451.USD","SGXZ23171101.USD","BK7511","VOTE","BK7501","BK7508","LU1169590202.USD","VGFPF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660454593","title":"Switzerland's Basilea H1 Revenue Rises on Cresemba Demand; Ups 2026 Profit Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2660454593","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660454593?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:26","pubTimestamp":1787030795,"startTime":"0","endTime":"0","summary":"Switzerland's Basilea H1 revenue rises on Cresemba demand; ups 2026 profit outlookOverviewSwitzerland biopharma firm's H1 2026 revenue grew 14% yr/yr to CHF 119 mlnOperating profit for H1 2026 rose 32","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL1N44F03R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1979443071.USD","HK0000306685.HKD","BK1230","BK0239","02696","LU1064131003.USD","002422","LU0196878994.USD","BK7067","00656","BK7501","BK0060","LU2148510915.USD","BK7508","CSL.AU","HK0000320264.USD","BK1161","HK0000165453.HKD","HK0000306701.USD","BK7511","06990","HK0000320223.HKD","LU1934453819.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660745574","title":"CSL's Fiscal 2026 Results In Line, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660745574","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660745574?lang=en_us&edition=fundamental","pubTime":"2026-08-18 10:00","pubTimestamp":1787018443,"startTime":"0","endTime":"0","summary":"CSL's  fiscal 2026 results are in line, and it guided for fiscal 2027 net profit after tax  growth of around 5%, Jefferies said in a Tuesday note.The firm's normalized fiscal 2026 net profit after tax and before amortization of $3.1 billion fell around 4% year-over-year and 2% in constant currency, compared with the brokerage's forecast of $3.09 billion.Its fiscal 2026 normalized earnings per share of $5.38 decreased around 3% on the year-ago period, compared with Jefferies' estimate of $5.76.Its fiscal 2027 revenue is expected by the firm to be in line with the prior year and underlying NPAT growth of around 5%, implying an underlying CSL fiscal 2027 NPAT of around $2.98 billion on a constant currency basis, compared with Jefferies' forecast of $2.8 billion on a non-constant currency basis.The investment firm assigned CSL a hold rating and a price target of AU$119 per share.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0728928796.USD","BK7511","BK4086","LU1169589451.USD","SG9999004303.SGD","SGXZ23171101.USD","BK7501","CSL.AU","BK7067","CSL","BK7508","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660453908","title":"Csl FY Adjusted Net Income USD 3,100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660453908","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660453908?lang=en_us&edition=fundamental","pubTime":"2026-08-18 09:02","pubTimestamp":1787014965,"startTime":"0","endTime":"0","summary":"BRIEF-Csl FY Adjusted Net Income USD 3,100 MillionAug 18 -CSL LimitedCSL.AX:FY ADJUSTED NET INCOME USD 3,100 MILLIONSEES FY UNDERLYING NPAT GROWTH OF  APPROXIMATELY 5%DIVIDEND MAINTAINED; SHARE BUY-BACK  PROGRAM CONTINUEDCSL SEQIRUS EXPECTS LOW SINGLE DIGIT REVENUE GROWTH IN FYSEES FY27 REVENUE TO BE IN LINE WITH THE PRIOR YEAR AND UNDERLYING NPAT GROWTH OF APPROXIMATELY 5%CSL BEHRING EXPECTS MID-SINGLE DIGIT REVENUE GROWTH IN FYANNOUNCE A FURTHER  A$1.1 BILLION SHARE BUY-BACK PROGRAMRECOGNISED PRE-TAX IMPAIRMENTS OF $5.5 BILLION IN 2H FY26INTENTION TO SPEND APPROXIMATELY $1.5 BILLION TO EXPAND ITS U.S. PLASMA  MANUFACTURING PRESENCEFurther company coverage:CSL.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nPLXMQ2BQ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7508","BK7511","BK7067","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660458382","title":"Shares of CSL Limited up 12.9% at A$152 in Early Trade After Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660458382","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660458382?lang=en_us&edition=fundamental","pubTime":"2026-08-18 08:02","pubTimestamp":1787011343,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44E0WX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7511","BK7067","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437278","title":"CSL FY26 Underlying NPATA Falls 2% to Us$3.1 Billion; Reported Net Loss Widens to Us$2.6 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437278","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437278?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:14","pubTimestamp":1787004898,"startTime":"0","endTime":"0","summary":"CSL FY26 underlying NPATA falls 2% to US$3.1 billion; reported net loss widens to US$2.6 billionCSL posted a net loss after tax of US$2.6 billion, swinging from profit, on one-off restructuring costs,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL2bJkFB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7067","BK7501","BK7508","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660371724","title":"CSL Final Dividend Us$1.62 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2660371724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660371724?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004013,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLX31HNDN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7067","BK7511","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437484","title":"CSL Limited - Announce a Further A$1.1 Billion Share Buy-Back Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437484","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437484?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","BK7067","CSL.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437482","title":"CSL Limited - Recognised Pre-Tax Impairments of $5.5 Billion in 2H FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437482?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","CSL.AU","BK7511","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437178","title":"CSL Limited Sees FY Underlying Npat Growth of Approximately 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437178","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437178?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7511","BK7067","BK7508","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660374874","title":"CSL Limited - Intention to Spend Approximately $1.5 Billion to Expand Its U.S. Plasma Manufacturing Presence","url":"https://stock-news.laohu8.com/highlight/detail?id=2660374874","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660374874?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","BK7501","CSL.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660371084","title":"CSL FY Adjusted Net Income USD 3,100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660371084","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660371084?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7067","BK7501","CSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660176437","title":"CSL Limited - CSL Seqirus Expects Low Single Digit Revenue Growth in FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2660176437","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660176437?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","BK7501","BK7067","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":82,"code":"91000000","status":"200"}]}}